Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
Leonie M. Weskamm, Anahita Fathi, Matthijs P. Raadsen, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100685-100685
Open Access | Times Cited: 22

Showing 22 citing articles:

Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
Beatriz Perdiguero, Patricia Pérez, Laura Marcos-Villar, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 15, pp. 168173-168173
Open Access | Times Cited: 20
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
Leonie Mayer, Leonie M. Weskamm, Anahita Fathi, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Matthijs P. Raadsen, Christine Dahlke, Anahita Fathi, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 4
Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein
Matthijs P. Raadsen, Christine Dahlke, Anahita Fathi, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 586-590
Open Access | Times Cited: 10
Beyond COVID-19: the promise of next-generation coronavirus vaccines
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
Mareike Kubinski, Jana Beicht, Isabel Zdora, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Suvro Biswas, Mohasana Akter Mita, Shamima Afrose, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25837-e25837
Open Access | Times Cited: 2
An Overview of Peptides and Peptide Pools for Antigen-Specific Stimulation in T-Cell Assays
Karsten Schnatbaum, Pavlo Holenya, Sebastian Pfeil, et al.
Methods in molecular biology (2024), pp. 29-50
Closed Access | Times Cited: 2
The Safety, Immunogenicity, and Optimal Dosing of an MVA-Based Vaccine Against MERS Coronavirus in Healthy Adults: A Phase 1b, Randomised, Placebo-Controlled, Double-Blind Clinical Trial
Matthijs P. Raadsen, Christine Dahlke, Anahita Fathi, et al.
(2024)
Closed Access | Times Cited: 2
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses
Abigail E. Powell, Hannah Caruso, Soyoon Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines
Mahmoud Kandeel, Mohamed A. Morsy, Hany M. Abd El‐Lateef, et al.
International Immunopharmacology (2023) Vol. 118, pp. 109998-109998
Open Access | Times Cited: 4
Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens
Leonie M. Weskamm, Christine Dahlke, Marylyn M. Addo
STAR Protocols (2022) Vol. 3, Iss. 4, pp. 101902-101902
Open Access | Times Cited: 7
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie M. Weskamm, Paulina Tarnow, Charlotte Harms, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110470-110470
Open Access
The BCG vaccine and SARS-CoV-2: Could there be a beneficial relationship?
Carlos A. Peña-Bates, Ricardo Lascuraín, Vianney Ortiz-Navarrete, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38085-e38085
Open Access
Revisiting MERS-CoV vaccination in the SARS-CoV-2 era
Sarah Batawi, Basem Alraddadi
The Lancet Infectious Diseases (2024)
Closed Access
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector
Ellen Kathrin Link, Alina Tscherne, Gerd Sutter, et al.
Vaccine (2024) Vol. 43, pp. 126521-126521
Open Access
Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances
Yuxiang Wang
Viruses (2023) Vol. 15, Iss. 8, pp. 1742-1742
Open Access | Times Cited: 1
ACE Configurator for ELISpot (ACE): Optimizing Combinatorial Design of Pooled ELISpot Assays with an Epitope Similarity Model
Jin Seok Lee, Dhuvarakesh Karthikeyan, Misha Fini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity model
Jin Seok Lee, Dhuvarakesh Karthikeyan, Misha Fini, et al.
Briefings in Bioinformatics (2023) Vol. 25, Iss. 1
Open Access
Validation of ligand tetramers for the detection of antigen-specific lymphocytes
Kristin Fitzpatrick, Hanna N. Degefu, Katrina Poljakov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top